Filing Details
- Accession Number:
- 0001562180-19-002723
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-08 18:40:02
- Reporting Period:
- 2019-05-06
- Accepted Time:
- 2019-05-08 18:40:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1271214 | Intersect Ent Inc. | XENT | Surgical & Medical Instruments & Apparatus (3841) | 200280837 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1354228 | Aaron David Lehman | C/O Intersect Ent, Inc. 1555 Adams Drive Menlo Park CA 94025 | General Counsel | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-06 | 9,000 | $18.00 | 30,795 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-05-06 | 9,000 | $33.02 | 21,795 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2019-05-07 | 11,952 | $0.00 | 33,747 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2019-05-06 | 9,000 | $0.00 | 9,000 | $18.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 76,000 | 2026-02-21 | No | 4 | M | Direct |
Footnotes
- Includes 17,000 Restricted Stock Units.
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2019.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.15, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents aright to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest on December 31, 2019.
- Includes 28,952 Restricted Stock Units.
- The vesting commencement date of the option was February 22, 2016. 25% of the shares subject to the option vested on February 22, 2017 and 1/48th of the remaining shares subject to the option will vest monthly thereafter over three (3) years.
Billionaire Hedge Funds
